1. The use of albuminuria as a measure of kidney damage 2. The findings in a Chinese (Asiatic) population which are likely to be different from previous analysis carried out in caucasic subjects
Major points
Beyond the linear and quartile analysis, I suggest performing an additional analysis using the appropriate cut-off for NAFLD in the chinese population (it is known that in caucasian subjects it is 60). It would be informative to know whether (and how) established NAFLD is associated with kidney damage.
It is not correct that the population is the largest ever surveyed. Similar analysis, including longitudinal observation, have been published in larger populations. (See Giorda C et al. Occurrence over time and regression of nonalcoholic fatty liver disease in type 2 diabetes. Diabetes Metab Res Rev. 2017 May;33(4)). I advice the authors to make comparisons with those data in the discussion section.
1.
The use of albuminuria as a measure of kidney damage 2.
The findings in a Chinese (Asiatic) population which are likely to be different from previous analysis carried out in caucasic subjects
Major points
Response: Thank you for your revision and we appreciate very much for your comments. The manuscript has certainly benefited from all these insightful suggestions. Originally, FLI＞60 was suggested to rule in fatty liver disease in Caucasian subjects. However, the optimal cutoff value of FLI for predicting fatty liver disease was different in Asian populations. Based on recent research, the FLI could accurately identify NAFLD and the optimal cut-off point was 30 in middle-aged and elderly Chinese [1] . Therefore, we classified the study population in non-current drinking group into two groups as follows: NAFLD group (FLI ≥ 30) and non-NAFLD group (FLI < 30). The prevalence of increased urinary albumin excretion was 51.6% and 29.6% in FLI established NAFLD and non-NAFLD group (P < 0.0001). Similar trends were detected in the prevalence of CKD (NAFLD group: 49.9%; non-NAFLD group: 31.5%, P < 0.0001). Compared with participants in the non-NAFLD group, those in NAFLD group had higher prevalence of increased urinary albumin excretion (OR 1.58, 95 % CI 1.18 -2.13) and CKD (OR 1.39, 95 % CI 1.05 -1.82) in multivariate logistic regression analyses. Related "Method and Result" was modified in the revised manuscript. ("Method" section, L205-208; "Result" section, L278 -284). Response: We appreciate very much for your comments and reminding. Actually, as the time of publication of the literature "Giorda C et al. Occurrence over time and regression of nonalcoholic fatty liver disease in type 2 diabetes. Diabetes Metab Res Rev. 2017 May;33(4)", we are sorry for the description by saying that the population is the largest ever surveyed. Because the value of FLI for evaluating lipid metabolism was quite different in Asian populations when compared with Caucasian subjects. Therefore, in the revised manuscript, we described the present study as the largest population-based study to explore the association of FLI with both albuminuria and CKD in Asian population.
Following your suggestion, we also discussed the interesting publication by Giorda C et al. in the revised manuscript and related information was presented as: "Recently, an interesting study by Giorda C et al. [1] reported that NAFLD is a dynamic condition in type 2 diabetes subjects and about 5% Italian diabetic patients entering or leaving FLI assessed NAFLD status every year. They found that male sex and established organ damage, especially kidney function, were independent risk predictors for the dynamic NAFLD condition in a longitudinal 3-year analysis. As the similarity in traditional risk factors for both NAFLD and CKD, relationship between the prevalence of earlier stages of kidney damage and the incidence of NAFLD is complex. Longitudinal observation of our cohort are needed to be carried out to determine whether such dynamic condition existed in the Chinese, especially in those with type 2 diabetes." ("Discussion" section, L355 -364).
In the end, thank you again for having given us the opportunity to revise the manuscript. The manuscript has certainly benefited from these insightful revision suggestions. We carefully addressed the comments point-by-point and changed our manuscript accordingly. Nevertheless, we are prepared to revise our manuscript further, should it be necessary.
[1]. Giorda C, Forlani G, Manti R, et al. Occurrence over time and regression of nonalcoholic fatty liver disease in type 2 diabetes. Diabetes/metabolism research and reviews 2017;33(4).
Reviewer: 2 Reviewer Name: DR OYEKOYA AYONRINDE Institution and Country: FIONA STANLEY HOSPITAL, AUSTRALIA Please state any competing interests or state 'None declared': NONE DECLARED Please leave your comments for the authors below The authors have examined associations between fatty liver index (FLI) as a surrogate for hepatic steatosis, and chronic kidney disease defined by reduced eGFR or albuminuria, in a large communitybased population of middle-aged and elderly adults in China. The manuscript addresses an important subject of 2 common conditions with some shared risk factors. It is mostly well-written though some English language editing is required, particularly in the earlier part of the paper. I have a few comments/ queries:
1. Despite the authors acknowledging the absence of a FLI threshold defining steatosis in their population, population estimates of NAFLD based on previous Chinese population studies or from previous studies comparing FLI with other methods of diagnosis steatosis would be useful.
Response: Thank you for your revision and we appreciate very much for your comments. The manuscript has certainly benefited from all these insightful suggestions.
Following your suggestion, we discussed the study that estimates of NAFLD based on previous Chinese population in the revised manuscript. "As a surrogate marker of histological fatty liver, FLI is defined as the accumulation of excessive liver fat. Based on the former researches, FLI has been proven accurate in detecting fatty liver against liver ultrasound and demonstrating the presence of hepatic fat against magnetic resonance spectroscopy [1] [2] [3] [4] ." "Originally, FLI＞60 was suggested to rule in NAFLD in Caucasian subjects. However, the optimal cutoff value of FLI for predicting NAFLD was different in Asian populations. Based on recent research, the FLI could accurately identify NAFLD and the optimal cut-off point was 30 in middle-aged and elderly Chinese [1] ." We also performing an additional analysis using the cut-off for NAFLD to analyses how established NAFLD is associated with kidney damage. We classified the study population in non-current drinking group into two groups as follows: NAFLD group (FLI ≥ 30) and non-NAFLD group (FLI < 30). The prevalence of increased urinary albumin excretion was 51.6% and 29.6% in FLI established NAFLD and non-NAFLD group (P < 0.0001). Similar trends were detected in the prevalence of CKD (NAFLD group: 49.9%; non-NAFLD group: 31.5%, P < 0.0001). Compared with participants in the non-NAFLD group, those in NAFLD group had higher prevalence of increased urinary albumin excretion (OR 1.58, 95 % CI 1.18 -2.13) and CKD (OR 1.39, 95 % CI 1.05 -1.82) in multivariate logistic regression analyses. Related "Method and Result" was modified in the revised manuscript. ("Method" section, L205-208; "Result" section, L278-284; "Discussion" section, L313-317). 2. Also, a reference to the local population prevalence of obesity and for the BMI threshold used to define obesity.
Response: We appreciate very much for your comments. Following your suggestion, we changed and cited the relevant references in the revised manuscript after a comprehensive literature search. Related "Methods and Discussion" was modified in the revised manuscript. "BMI was calculated as weight in kilograms divided by height in meters squared (kg/m2). Obesity was defined as BMI equal or greater than 28 and overweight was defined as BMI equal or greater than 24 and less than 28 [1] ." "Methods" section, L171 -173" "Prevalence of obesity was 7.9% (8.4% in males and 7.6% in females) in southern China, which has increased dramatically over the past several decades [2] ." "Discussion" section, L305 -306" 3. An important omission is a comment regarding the local epidemiology of HBV and HCV, which are both prevalent in China and can be associated with liver disease and kidney disease. Were they checked in the cohort? This is a potential limitation.
Response: We appreciate very much for your comments. Viral hepatitis infection is prevalent in China and can be associated with liver disease and kidney disease. We do agree with you that lack of the local epidemiologic data of HBV and HCV is a potential limitation of the present study.
Following your suggestion, we discussed such limitation in the revised manuscript: "Viral hepatitis infection is one of the most serious infectious diseases worldwide, which can be associated with both liver and kidney disease. Recent survey data showed that the hepatitis B surface antigen and antihepatitis C virus-positive rates were already 6.1% and 3.0% in China [1] . Epidemiology of viral hepatitis infection by hepatitis B virus (HBV) and hepatitis C virus (HCV) serological testing, therefore, should be also be evaluate to strength the findings of the present study." "Discussion" section, L395-401" 4. Creatinine results should be included in Table 1 .
Response: Such information was missing in the original manuscript. Thank you very much for your reminding. Related information of creatinine results was presented in the revised manuscript in Table  1. 5. The study cited in reference 2 is a survey conducted between 2007 and 2010, though published in 2012.
Response: Thank you very much for the revision. Related study was cited and modified in the revised manuscript as "Recent national survey conducted between 2007 and 2010 reported that the prevalence of CKD was 10.8%, representing an estimated 119.5 million patients in China with chronic kidney damage [1] ." "Introduction" section, L108 -110" 6. It is a pity that alcohol intake was not quantified, as this influences the FLI and doesn't permit comparisons between and within alcoholic and nonalcoholic fatty liver disease groups.
Response: We appreciate very much for your comments. Following your suggestion, we further discussed such limitation in the revised manuscript: "A significant association of FLI with increased urinary albumin excretion and CKD only detected in subjects without current alcohol consumption. Average daily alcohol intake influences the FLI and missing such data in the present study doesn't permit comparisons between and within alcoholic and nonalcoholic fatty liver disease groups. To better discriminate alcoholic fatty liver disease and nonalcoholic fatty liver disease, further studies need to clearly described the precise exposure of alcohol use by collecting histories of alcohol intake in a quantitative manner." "Discussion" section, L388 -395" 7. The term fatty degeneration of the liver is an old fashioned term, no longer in general use.
Response: We agree with your suggestion and "fatty degeneration of the liver" was changed to "steatosis in hepatic tissue" in the revised manuscript. Related section was modified in the revised manuscript as "The noninvasive technique is not sensitive enough to detect mild steatosis and does not allow precise quantification of severity of steatosis in hepatic tissue." and "The superiority of this non-invasive assessment techniques is that a higher score will indicate a higher degree of steatosis in hepatic tissue." "Discussion" section, L311 -313 & L317 -318"
8. There is conflicting data regarding amounts of alcohol consumed and both insulin sensitivity and albuminuria that may be worth incorporating in the discussion.
Response: We appreciate very much for your comments. Following your suggestion, we discussed recent conflicting data regarding amounts of alcohol consumed with both insulin sensitivity and albuminuria. Related section was modified in the revised manuscript as "Alcohol consumption can profoundly disturb the lipid metabolism which have prominent effects on the hepatic tissue steatosis and insulin sensitivity [1] . However, potential health effects regarding alcohol consumption in this field is also worth attaching attention. A meta-analysis of intervention studies by Schrieks et al [2] . showed that moderate alcohol intake could improve insulin sensitivity by decreasing fasting insulin level in women. Recently, a prospective cohort study found that alcohol consumption was consistently inversely associated with urinary albumin excretion and the risk of developing CKD [3] . Therefore, advice concerning alcohol consumption to subjects with lowgrade hepatic tissue steatosis should consider the full range of benefits and risks, especially among those who drink moderately." "Discussion" section, L365 -374" [1] . Parker R, Kim SJ, Gao B. Alcohol, adipose tissue and liver disease: mechanistic links and clinical considerations. Nature reviews Gastroenterology & hepatology 2017. [2] . Schrieks IC, Heil AL, Hendriks HF, et al. The effect of alcohol consumption on insulin sensitivity and glycemic status: a systematic review and meta-analysis of intervention studies. Diabetes care 2015;38(4):723-32. [3] . Koning SH, Gansevoort RT, Mukamal KJ, et al. Alcohol consumption is inversely associated with the risk of developing chronic kidney disease. Kidney international 2015;87(5):1009-16. 9. Abbreviations SBP and DBP need to be expanded to systolic blood pressure and diastolic blood pressure somewhere in the text, though shown in Table 1 .
Comment: Further English language editing is required.
Response: We appreciate very much for your comments and reminding. Following your suggestion, we have carefully checked our manuscript again and invited a native English speaker to recheck the revised manuscript -R2.
Comment: As a limitation it should be expressed that the calculated FLI may relate to various liver diseases with associated steatosis and not only NAFLD, despite the fact that metabolic disturbances make obesity related steatosis likely.
Response: We appreciate very much for your comments. Following your suggestion, we discussed such limitation in the revised manuscript: "… when evaluating the findings of the present study, the results should be interpreted cautiously due to possible bias from using the indirect indicator FLI to assess fatty liver disease. The calculated FLI may relate to various liver diseases with associated steatosis and not only NAFLD, despite the fact that metabolic disturbances make obesity related steatosis likely. The internal accuracy of FLI for evaluation hepatic steatosis should also be validated by using other techniques, before it can be employed for these purposes." "Discussion" section, L387-394" Comment: A concluding comment on why CKD or albuminuria is relevant to chronic liver disease or steatosis is worth considering i.e. the implications of the findings.
Response: We appreciate very much for your comments and reminding. The concluding comment of the study was modified and presented in the Discussion section of the revised manuscript as "In conclusion, by including a large population based cohort, the present study provides evidence that increased FLI is independently associated with prevalence of albuminuria and CKD. Findings of the present study suggested us should pay more attention to albuminuria and eGFR variation in patients with dyslipidemia and fatty liver disease. Further prospective studies are necessary to verify our findings in external populations." "Discussion" section, L413-418"
In the end, thank you again for having given us the opportunity to revise the manuscript. We carefully addressed the comments point-by-point and changed our manuscript accordingly. Nevertheless, we are prepared to revise our manuscript further, should it be necessary.
